BMJ  2005;330 (11 June), doi:10.1136/bmj.330.7504.0-c

Celecoxib seems to be the choice for congestive heart failure

Celecoxib currently seems to be the safest choice for treating elderly patients with congestive heart failure. Hudson and colleagues (p 1370) undertook a retrospective cohort study that included more than 2000 patients aged 66 or more who were prescribed celecoxib, rofexocib, or a non-steroidal anti-inflammatory drug (NSAID) at their index admission for congestive heart failure. The combined risk of death and recurrent congestive heart failure was higher in patients prescribed NSAIDs or rofexocib than in those prescribed celecoxib (hazard ratios 1.26 and 1.27, respectively).

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study

Marie Hudson, Hugues Richard, and Louise Pilote
BMJ 2005 330: 1370. [Abstract] [Full Text] [PDF]

Online poll

Find out more >>